Most companies in the life science industry must conduct some form of human clinical studies to bring their product to market:
  • If conducting domestic trials, is your insurance program in compliance with the facility or IRB overseeing the trial?
  • For multinational trials, are you aware of the jurisdictional insurance requirements in each country where you will be conducting a clinical trial?
  • Failure to have the proper insurance can lead to delays. In drug development, delays can equal millions of dollars.